Mario Ammirati

Mario Ammirati

Auto-generated profile, based on publicly available information

Mario Ammirati

Center for Biotechnology Department of Biology, College of Science and Technology, Temple University, Philadelphia, USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2019 in Neurosurgery
Verified
Journal Article
Open access
PDF file
MAMario Ammirati
Mario Ammirati
BNBrian V Nahed
Brian V Nahed
DADavid Andrews
David Andrews
CCClark C Chen
Clark C Chen
JOJeffrey J Olson
Jeffrey J Olson
TARGET POPULATION: These recommendations apply to adult patients newly diagnosed with multiple (more than 1) brain metastases. QUESTION 1: In what circumstances should whole brain radiation therapy be recommended to improve tumor control and survival in patients with multiple brain metastases? RECOMMENDATION: Level 2: It is recommended that whole brain radiation therapy can be added to stereotactic radiosurgery to improve local and distant control keeping in mind the potential for worsened neurocognitive outcomes and that there is unlikely to be a significant impact on overall survival. QUESTION 2: In what circumstances should stereotactic radiosurgery be recommended to improve tumor control and survival in patients with multiple brain metastases? RECOMMENDATIONS: Level 1: In patients with 2 to 3 brain metastases not amenable to surgery, the addition of stereotactic radiosurgery to whole brain radiation therapy is not recommended to improve survival beyond that obtained with whole brain radiation therapy alone. Level 3: The use of stereotactic radiosurgery alone is recommended to improve median overall survival for patients with more than 4 metastases having a cumulative volume < 7 cc. QUESTION 3: In what circumstances should surgery be recommended to improve tumor control and survival in patients with multiple brain metastases? RECOMMENDATION: Level 3: In patients with multiple brain metastases, tumor resection is recommended in patients with lesions inducing symptoms from mass effect that can be reached without inducing new neurological deficit and who have control of their cancer outside the nervous system. The full guideline can be found at https://www.cns.org/guidelines/guidelines-treatment-adults-metastatic-brain-tumors/chapter_6.

1 January 2002 in Journal of Neurological Surgery Part B: Skull Base
Verified
Journal Article
Open access
MAMario Ammirati
Mario Ammirati
JGJeffrey D. Gross
Jeffrey D. Gross
GAgiuseppe ammirati
giuseppe ammirati
SDSharon Dugan
Sharon Dugan
The registration accuracy of skin- and bone-implanted fiducials using a frameless stereotactic system were analyzed prospectively.Twenty-eight patients underwent resection of intra-axial neoplasmas after both skin- and bone-implantable fiducial markers were placed. Both sets of fiducials were independently co-registered to a magnetic resonance imaging data set acquired preoperatively using the ISG Viewing Wandtrade mark. Root mean square errors were recorded as an objective measure of registration accuracy of the two types of fiducials.Root mean square errors of bone-implanted fiducials registration were lower than those of skin fiducials; however, this difference was not statistically significant (p = 0.206).The registration accuracy of skin- and bone-implanted fiducials appears to be similar. Still, bone-implanted fiducials may be advantageous compared to skin fiducials when re-registration of the patient-image space is desired intraoperatively such as during major drift in the patient's position or after surgical repositioning.

18 December 2012 in Neurosurgical Review
Verified
Journal Article
Closed access
PDF file
CTChi-Tun Tang
Chi-Tun Tang
NBNishanta B. Baidya
Nishanta B. Baidya
MAMario Ammirati
Mario Ammirati

25 April 2015 in Neurosurgical Review
Verified
Journal Article
Closed access
PDF file
RCRoberto Colasanti
Roberto Colasanti
ATAl-Rahim Abbasali Tailor
Al-Rahim Abbasali Tailor
JZJun Zhang
Jun Zhang
MAMario Ammirati
Mario Ammirati

26 February 2018 in Acta Neurochirurgica
Verified
Journal Article
Closed access
PDF file
PWPengfei Wu
Pengfei Wu
RCRoberto Colasanti
Roberto Colasanti
JLJungshun Lee
Jungshun Lee
ASAlba Scerrati
Alba Scerrati
SESerdar Ercan
Serdar Ercan
MAMario Ammirati
Mario Ammirati

16 December 2010 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
PDF file
MAMario Ammirati
Mario Ammirati
KSKonstantinos Spiliopoulos
Konstantinos Spiliopoulos
CEClara Raquel Epstein
Clara Raquel Epstein
JGJosue Gabriel
Josue Gabriel
EBEric C Bourekas
Eric C Bourekas
Preoperative direct percutaneous embolization has been very rarely used in hypervascular metastatic spinal tumors to decrease blood loss during the surgery. A patient is presented with solitary spinal metastasis due to renal cell carcinoma who underwent a two-stage spondylectomy. Transarterial tumor embolization with polyvinyl alcohol (PVA) particles and liquid coil placement, and percutaneous tumor embolization with PVA particles were used before the first and the second stage, respectively.